Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SEAR, J. W.
Right arrow Articles by GLEN, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SEAR, J. W.
Right arrow Articles by GLEN, J. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1995, Vol. 74, No. 4 362-367
© 1995 The Board of Management and Trustees of the British Journal of Anaesthesia


research-article

Propofol administered by a manual infusion regimen

J. W. SEAR, MA, BSC, PHD, FRCA and J. B. GLEN, BVMS, PHD, DVA

Nuffield Department of Anaesthetics, University of Oxford, John Radcliffe Hospital Headington, Oxford
Medical Affairs Department, Zeneca Pharmaceuticals Macclesfield, Cheshire

Correspondence to J. W. S.

We have evaluated the clinical utility and blood propofol concentrations produced with two dif ferent infusion regimens for propofol, given to supplement 67% nitrous oxide-morphine anaesthesia. Patients received a standardized three-step infusion of propofol based either on body weight (weight-corrected group) or on a mean body weight of 70 kg (standard dose group). Both groups showed similar cardiovascular stability and recovery times. In the 48 patients studied, isoflurane was used as a supplement in nine (two in the weight-corrected group). Apparent steady state blood propofol concentrations were 3.41 (SD 0.69) µg ml–1 in the weight-corrected group and 3.46 (0.79) µg ml–1 in the standard dose group. These results suggest that for patients weighing 60–90 kg body weight, a standard dose infusion regimen may be a suitable starting point. In routine clinical practice, the need for isoflurane supplementation may be avoided by subsequent titration of the infusion rate according to clinical response. Computer simulation of the actual infusion rates used in each patient has allowed retrospective comparison of the predictive performance of different pharmaco kinetic descriptors for propofol. The variables described by Tackley and colleagues provided a more accurate prediction of the measured blood propofol concentration than did the variable set reported by Gepts and colleagues.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.